Latest news and stories about obesity medications in Portugal for expats and residents.
Data from the National Association of Pharmacies indicates that the “significant growth” in 2025 was “mainly driven by the entry of Mounjaro and Wegovy” into the market in Portugal.
Growing demand. In 2019, 45,787 packages were sold; by 2025, more than half a million. Experts have called for subsidies for these drugs.
Medications are not subsidised and can cost over 300 euros per month.
The WHO has recommended for the first time to expand the use of a class of medications used for diabetes and weight loss to treat obesity, which affects one billion people.
